With obesity rates shooting up, I'd have bet on the sales of generic GLP-1s exploding once their patents expired." Kamath added that despite evidence suggesting benefits beyond weight loss, including cardiovascular, metabolic, and liver health, adoption appears to be slower than expected
Ben Greenfield: All right
Ongoing Support To ensure effective progress monitoring, regular check-ins will be scheduled, with on-demand medical support available to address any concerns
Tesamorelin's adverse-event profile from the Phase III program is dominated by injection-site reactions (~25% of patients), arthralgia, peripheral oedema, paresthesia, and a clinically meaningful rise in IGF-1 that occasionally exceeds the upper limit of normal
This degradation happens continuously